Evaluation of antenatal risk factors for postpartum depression: a secondary cohort analysis of the cluster-randomised GeliS trial.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
24 07 2020
Historique:
received: 20 02 2020
accepted: 23 06 2020
entrez: 25 7 2020
pubmed: 25 7 2020
medline: 11 2 2021
Statut: epublish

Résumé

Maternal weight variables are important predictors of postpartum depression (PPD). While preliminary evidence points to an association between pre-pregnancy obesity and PPD, the role of excessive gestational weight gain (GWG) on PPD is less studied. In this secondary cohort analysis of the German 'healthy living in pregnancy' (GeliS) trial, we aimed to investigate associations between weight-related variables and PPD and to assess the influence of GWG on the risk for PPD. We included women with normal weight, overweight, and obesity (BMI 18.5-40.0 kg/m Of the total 1583 participants, 45.6% (n = 722) showed excessive GWG and 7.9% (n = 138) experienced PPD. Pre-pregnancy BMI (per 5-unit increase; OR = 1.23, 95% CI 1.08-1.41, p = 0.002) and pre-pregnancy overweight or obesity were significantly positively associated with the odds of developing PPD, particularly among women with an antenatal history of anxiety or depressive symptoms (overweight: OR = 1.93, 95% CI = 1.15-3.22, p = 0.01; obesity: OR = 2.11, 95% CI = 1.13-3.96, p = 0.02). Sociodemographic or lifestyle factors did not additively influence the odds of having PPD. In fully adjusted models, there was no significant evidence that GWG or the occurrence of excessive GWG increased the odds of experiencing PPD (excessive vs. non-excessive: OR = 3.48, 95% CI 0.35-34.94; GWG per 1 kg increase: OR = 1.16, 95% CI 0.94-1.44). Pre-pregnancy overweight or obesity is associated with PPD independent of concurrent risk factors. History of anxiety or depressive symptoms suggests a stress-induced link between pre-pregnancy weight and PPD. NCT01958307 , ClinicalTrials.gov, retrospectively registered on 9 October 2013.

Sections du résumé

BACKGROUND
Maternal weight variables are important predictors of postpartum depression (PPD). While preliminary evidence points to an association between pre-pregnancy obesity and PPD, the role of excessive gestational weight gain (GWG) on PPD is less studied. In this secondary cohort analysis of the German 'healthy living in pregnancy' (GeliS) trial, we aimed to investigate associations between weight-related variables and PPD and to assess the influence of GWG on the risk for PPD.
METHODS
We included women with normal weight, overweight, and obesity (BMI 18.5-40.0 kg/m
RESULTS
Of the total 1583 participants, 45.6% (n = 722) showed excessive GWG and 7.9% (n = 138) experienced PPD. Pre-pregnancy BMI (per 5-unit increase; OR = 1.23, 95% CI 1.08-1.41, p = 0.002) and pre-pregnancy overweight or obesity were significantly positively associated with the odds of developing PPD, particularly among women with an antenatal history of anxiety or depressive symptoms (overweight: OR = 1.93, 95% CI = 1.15-3.22, p = 0.01; obesity: OR = 2.11, 95% CI = 1.13-3.96, p = 0.02). Sociodemographic or lifestyle factors did not additively influence the odds of having PPD. In fully adjusted models, there was no significant evidence that GWG or the occurrence of excessive GWG increased the odds of experiencing PPD (excessive vs. non-excessive: OR = 3.48, 95% CI 0.35-34.94; GWG per 1 kg increase: OR = 1.16, 95% CI 0.94-1.44).
CONCLUSION
Pre-pregnancy overweight or obesity is associated with PPD independent of concurrent risk factors. History of anxiety or depressive symptoms suggests a stress-induced link between pre-pregnancy weight and PPD.
TRIAL REGISTRATION
NCT01958307 , ClinicalTrials.gov, retrospectively registered on 9 October 2013.

Identifiants

pubmed: 32703266
doi: 10.1186/s12916-020-01679-7
pii: 10.1186/s12916-020-01679-7
pmc: PMC7379365
doi:

Banques de données

ClinicalTrials.gov
['NCT01958307']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

227

Subventions

Organisme : Else Kröner-Fresenius Centre for Nutritional Medicine
ID : NA
Pays : International
Organisme : Competence Centre for Nutrition (KErn)
ID : NA
Pays : International
Organisme : Bayerisches Staatsministerium für Ernährung, Landwirtschaft und Forsten (DE)
ID : NA
Pays : International
Organisme : Bavarian State Ministry of Health and Care (Health Initiative "Gesund.Leben.Bayern.")
ID : NA
Pays : International
Organisme : AOK Bayern
ID : NA
Pays : International
Organisme : DEDIPAC consortium by the Joint Programming Initiative (JPI) "A Healthy Diet for a Healthy Life"
ID : NA
Pays : International

Références

BMC Pregnancy Childbirth. 2014 Mar 28;14:119
pubmed: 24678761
Paediatr Perinat Epidemiol. 2014 May;28(3):203-12
pubmed: 24673550
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
Dialogues Clin Neurosci. 2011;13(1):41-53
pubmed: 21485745
J Affect Disord. 2018 Nov;240:193-198
pubmed: 30077160
Annu Rev Clin Psychol. 2015;11:99-137
pubmed: 25822344
Dtsch Med Wochenschr. 2012 Jun;137(25-26):1366-72
pubmed: 22692838
Psychopathology. 2016;49(4):269-276
pubmed: 27497959
Horm Behav. 2016 Jan;77:153-66
pubmed: 26319224
J Health Psychol. 2012 Apr;17(3):333-42
pubmed: 21824894
Acta Psychiatr Scand. 2008 Dec;118(6):459-68
pubmed: 18840256
Paediatr Perinat Epidemiol. 2018 Mar;32(2):152-160
pubmed: 29345321
Matern Child Health J. 2006 Jul;10(4):385-90
pubmed: 16673179
Psychosom Med. 2000 Mar-Apr;62(2):264-70
pubmed: 10772407
Matern Child Health J. 2012 Apr;16(3):656-67
pubmed: 21533884
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
J Clin Psychiatry. 2009 Sep;70(9):1290-6
pubmed: 19607761
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):3-12
pubmed: 24140480
BMC Med. 2019 Jan 14;17(1):5
pubmed: 30636636
J Clin Med. 2019 Jun 19;8(6):
pubmed: 31248138
Int J Gynaecol Obstet. 2005 Nov;91(2):125-31
pubmed: 16202415
Health Psychol. 2015 Mar;34(3):274-8
pubmed: 25110848
Clin Obstet Gynecol. 2018 Sep;61(3):591-603
pubmed: 29596076
Compr Psychiatry. 2003 May-Jun;44(3):234-46
pubmed: 12764712
Can J Public Health. 2016 Mar 16;106(8):e563
pubmed: 26986920
Am J Epidemiol. 1999 Nov 1;150(9):947-56
pubmed: 10547140
Psychoneuroendocrinology. 2013 Oct;38(10):1929-52
pubmed: 23608136
BMC Pregnancy Childbirth. 2019 Nov 11;19(1):414
pubmed: 31711430
Obstet Gynecol. 1995 Aug;86(2):177-83
pubmed: 7617346
J Midwifery Womens Health. 2018 Mar;63(2):178-184
pubmed: 29569357
BMJ Open. 2014 Nov 14;4(11):e004883
pubmed: 25398675
Am J Perinatol. 2020 Jan;37(1):19-24
pubmed: 31382300
Obesity (Silver Spring). 2009 Sep;17(9):1678-83
pubmed: 19300426
Ann Epidemiol. 2017 Nov;27(11):695-700.e1
pubmed: 29110970
J Clin Med. 2019 Jul 02;8(7):
pubmed: 31269753
Obstet Gynecol. 2015 Dec;126(6):e135-42
pubmed: 26595585
Depress Anxiety. 2017 Feb;34(2):178-187
pubmed: 28098957
BJOG. 2010 Jul;117(8):1011-8
pubmed: 20536433
Arch Womens Ment Health. 2005 Jun;8(2):97-104
pubmed: 15883652
J Neuroendocrinol. 2014 Oct;26(10):665-84
pubmed: 25059408
J Pregnancy. 2018 Oct 21;2018:9315320
pubmed: 30420921
Nutr J. 2010 Sep 14;9:36
pubmed: 20840739
Arch Womens Ment Health. 2005 May;8(1):29-35
pubmed: 15868391
Gen Hosp Psychiatry. 2004 Jul-Aug;26(4):289-95
pubmed: 15234824
J Psychiatr Res. 2018 Sep;104:235-248
pubmed: 30114665
JAMA. 2019 May 7;321(17):1702-1715
pubmed: 31063572
Nurs Res. 2001 Sep-Oct;50(5):275-85
pubmed: 11570712
Br J Psychiatry. 1991 Jan;158:46-52
pubmed: 2015451
Dtsch Med Wochenschr. 1998 Jan 16;123(3):35-40
pubmed: 9472218

Auteurs

Hamimatunnisa Johar (H)

Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Department of Psychosomatic Medicine and Psychotherapy, Justus-Liebig University of Giessen and Marburg, Giessen, Friedrichstr. 33, 35392, Gießen, Germany.

Julia Hoffmann (J)

Institute of Nutritional Medicine, Else Kröner-Fresenius-Centre for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 62, 80992, Munich, Germany.

Julia Günther (J)

Institute of Nutritional Medicine, Else Kröner-Fresenius-Centre for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 62, 80992, Munich, Germany.

Seryan Atasoy (S)

Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Department of Psychosomatic Medicine and Psychotherapy, Justus-Liebig University of Giessen and Marburg, Giessen, Friedrichstr. 33, 35392, Gießen, Germany.

Lynne Stecher (L)

Institute of Nutritional Medicine, Else Kröner-Fresenius-Centre for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 62, 80992, Munich, Germany.

Monika Spies (M)

Institute of Nutritional Medicine, Else Kröner-Fresenius-Centre for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 62, 80992, Munich, Germany.

Hans Hauner (H)

Institute of Nutritional Medicine, Else Kröner-Fresenius-Centre for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Georg-Brauchle-Ring 62, 80992, Munich, Germany. hans.hauner@tum.de.

Karl-Heinz Ladwig (KH)

Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany. Karl-Heinz.Ladwig@tum.de.
Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universität München, Langerstr. 3, 81675, Munich, Germany. Karl-Heinz.Ladwig@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH